#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

AstraZeneca profit falls

Share on Twitter Share on LinkedIn
Christian Fernsby ▼ | February 14, 2020
AstraZeneca's annual profit fell 14% as rising costs and higher asset writedowns offset sales increases at the pharmaceutical company.
AstraZeneca
AstraZeneca   Operating profit for the year to the end of December declined to $2.9bn
Operating profit for the year to the end of December declined to $2.9bn from $3.4bn a year earlier as revenue rose 10% to $24.4bn. Excluding currency changes, operating profit dropped 16% and sales increased 13%.

Topics: AstraZeneca

Pretax profit fell to $1.55bn from $1.99bn. The company's core earnings per share meanwhile rose 1% to $3.50.

The final quarter showed a deterioration in performance as revenue unadjusted for currency changes rose 4% to $6.7bn and operating profit fell 46% to $577m. Core earnings dropped 44% to 89 cents a share.

The FTSE 100 company said it expected 2020 revenue to rise by a percentage in the high single digits or low double digits and for core earnings to improve by a mid to high teens percentage. The guidance assumes a few months of impact from the coronavirus outbreak.


 

MORE INSIDE POST